Johnson & Johnson (JNJ)

125.95
1.80 1.40
NYSE : Health Technology
Prev Close 127.76
Day Low/High 125.32 / 127.50
52 Wk Low/High 118.62 / 148.32
Avg Volume 6.32M
Exchange NYSE
Shares Outstanding 2.68B
Market Cap 342.67B
EPS 0.50
P/E Ratio 277.74
Div & Yield 3.60 (2.71%)

Latest News

Jim Cramer: This Market Isn't Done Going Higher

Jim Cramer: This Market Isn't Done Going Higher

We aren't done moving higher even with the president ready to strike at a moment's notice against any of our allies.

Jim's Daily Rundown

Jim discusses JPMorgan and Citigroup, and also talks about Instagram and Facebook!

Johnson & Johnson Tumbles After $4.7 Billion Baby Powder-Cancer Link Verdict

Johnson & Johnson Tumbles After $4.7 Billion Baby Powder-Cancer Link Verdict

Johnson & Johnson was ordered to pay $4.69 billion to 22 women who alleged the company's talc-based products caused them to develop ovarian cancer.

JPMorgan, AT&T-Time Warner, J&J, Apple and Blue Origin - 5 Things You Must Know

JPMorgan, AT&T-Time Warner, J&J, Apple and Blue Origin - 5 Things You Must Know

U.S. stock futures rise as earnings season gets started with reports from big U.S. banks; the Justice Department appeals the approval of the AT&T-Time Warner merger; J&J is ordered to pay $4.7 billion in a talcum powder case.

Stocks Rise Modestly and 4 Other Stories to Watch Premarket Friday

Stocks Rise Modestly and 4 Other Stories to Watch Premarket Friday

Happy Friday the 13th! These are the stories moving the market ahead of today's opening bell.

Johnson & Johnson Hit by $4.7 Billion Jury Verdict in Ovarian Cancer Case

Johnson & Johnson Hit by $4.7 Billion Jury Verdict in Ovarian Cancer Case

Johnson & Johnson must pay 22 women who claimed the company's baby powder contained asbestos that gave them ovarian cancer.

St. Louis Jury Returns $4.69 Billion Verdict In First Trial Linking Baby Powder, Asbestos And Ovarian Cancer

St. Louis Jury Returns $4.69 Billion Verdict In First Trial Linking Baby Powder, Asbestos And Ovarian Cancer

ST. LOUIS, July 12, 2018 /PRNewswire/ -- A jury has awarded $4.

REPLAY: Jim Cramer on Broadcom, CA, Johnson & Johnson, Citigroup & Canopy Growth

REPLAY: Jim Cramer on Broadcom, CA, Johnson & Johnson, Citigroup & Canopy Growth

TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Thursday's trending stocks from the floor of the New York Stock Exchange

Why Jim Cramer Is Bullish on Johnson & Johnson Shares

Why Jim Cramer Is Bullish on Johnson & Johnson Shares

TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer is bullish on Johnson & Johnson shares.

Jim Cramer: This Market Is Not as Expensive as It Looks

Jim Cramer: This Market Is Not as Expensive as It Looks

The only way the market is "dangerously elevated" is if you believe that 2019 is going to be a horrendous year.

Elliott Tackles AC Milan After Chinese Investors Falter; Pfizer Eyes Reorg-ICYMI

Elliott Tackles AC Milan After Chinese Investors Falter; Pfizer Eyes Reorg-ICYMI

Here's what you need to know now for Wednesday, July 11.

Pfizer Announces Big Reorganization As It Continues Trying to Sell Consumer Biz

Pfizer Announces Big Reorganization As It Continues Trying to Sell Consumer Biz

The changes will take effect at the start of 2019.

General Electric's Stock Is Attractive for the First Time in 2 Years: Jim Cramer

General Electric's Stock Is Attractive for the First Time in 2 Years: Jim Cramer

Jim Cramer says earnings could break the tie between the bulls and the bears -- unless China blinks. Here's the game plan for next week.

More Activity in the Bullpen

We are adding Johnson & Johnson, Clorox and Procter & Gamble and removing eBay.

The New #14 Most Shorted Dow Component: Johnson & Johnson

The New #14 Most Shorted Dow Component: Johnson & Johnson

The most recent short interest data has been released for the 06/15/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Dow Jones Industrial Average by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

How to Position Your Portfolio Against Threats Like Trade Wars and Recessions

How to Position Your Portfolio Against Threats Like Trade Wars and Recessions

Threats are out there that investors always need to consider. Are you prepared?

Finding Stocks Right for You: Cramer's 'Mad Money' Recap (Friday 6/29/18)

Finding Stocks Right for You: Cramer's 'Mad Money' Recap (Friday 6/29/18)

Jim Cramer says it's extremely important to buy stocks that are exactly right for you and your level of risk tolerance.

See How Johnson & Johnson Ranks Among Analysts' Top Dow 30 Picks

See How Johnson & Johnson Ranks Among Analysts' Top Dow 30 Picks

A study of analyst recommendations at the major brokerages shows that Johnson & Johnson is the #23 broker pick, on average, out of the 30 stocks making up the Dow Jones Industrial Average, according to ETF Channel. Within the broader S&P 500, when components were ranked in terms of analyst favorites, JNJ claims the #349 spot.

Champions Of Science: The Art Of Ending Stigma Project Launches To Combat Stigma About Mental Illnesses Through Education And Artistic Creation

Champions Of Science: The Art Of Ending Stigma Project Launches To Combat Stigma About Mental Illnesses Through Education And Artistic Creation

- New survey shows that widespread stigma surrounds mental illnesses and many people struggle with how they can help

Johnson & Johnson Appoints Senior Leaders To Executive Committee

Johnson & Johnson Appoints Senior Leaders To Executive Committee

NEW BRUNSWICK, N.J.

Crowning Achievement: Six Dividend Kings With 50+ Years of Rising Dividends

Crowning Achievement: Six Dividend Kings With 50+ Years of Rising Dividends

These 'recession-resistant' names have proven they can thrive in a variety of economic conditions and through changing technologies and sentiments.

The Charts and Indicators on Johnson & Johnson Are Still Mostly Bearish

The Charts and Indicators on Johnson & Johnson Are Still Mostly Bearish

Johnson & Johnson is among the companies that Jim Cramer has put on his new GLOOM index.

Global Gloom: Cramer's 'Mad Money' Recap (Monday 6/18/18)

Global Gloom: Cramer's 'Mad Money' Recap (Monday 6/18/18)

Jim Cramer says we need stocks that are in sync with the global gloom and can be bought when we feel gloomy, which is pretty much every day.

12 Stocks That Make Up the GLUM Index

12 Stocks That Make Up the GLUM Index

Here is a new index for all you traders out there to follow, compliments of TheStreet's founder Jim Cramer. Welcome to the GLUM Index.

3 Great Stocks for Retirees to Own

3 Great Stocks for Retirees to Own

Looking for stocks with a steady stream of income? Check these three names out from TheStreet.

TheStreet Quant Rating: B (Buy)